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Usefulness of the Palliative Prognostic Index for advanced cancer patients in the home 
care setting 
 
Introduction 
Prognostic prediction is necessary for advanced cancer patients, especially those in 
the home care setting, in order to determine treatment goals, the content and location of 
provided care, and indications for hospital referral.1) An appropriate prognostic 
prediction tool is therefore essential not only for patients and their families, but also for 
the healthcare professionals who support their decision making.2) Previous studies have 
examined several prognostic prediction tools for cancer patients, for example the 
Palliative Prognostic Index (PPI),3) Palliative Performance Scale,3) Cancer Prognostic 
Scale,3) Palliative Prognostic Scale,4) Japan Palliative Oncology Study-Prognostic Index 
(J-POS-PI),5) and Prognosis in Palliative Care Study model,6) and each was properly 
validated. These tools are intended for use in assessing inpatient and ambulatory 
patients, and the appropriateness of their application to advanced cancer patients in the 
home care setting is uncertain. Only Stone et al. prospectively studied the usefulness of 
the PPI in 194 cancer patients in a variety of settings: 73.7% of patients were 
hospitalized, 25.8% were in the home care setting, and 0.5% were in hospice.8) 
The PPI was defined based on performance status assessment using the Palliative 
Performance Scale (PPS), oral intake, and the presence or absence of dyspnea, edema, 
and delirium (Table 1). The PPI does not require blood tests or radiological evaluation, 
and would therefore be very useful for cancer patients in the home care setting as 
compared to other validated prognostic prediction tools. Each PPI component is 
assigned an individual score, and these are added to derive the overall score. The final 
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PPI score classifies patients into 1 of 3 groups: those with survival predicted to be 
shorter than 3 weeks (PPI ≥6), shorter than 6 weeks (PPI ≥4), or more than 6 weeks 
(PPI <4). 
The PPI was developed and successfully validated for cancer patients in palliative care 
units by Morita et al. in Japan,7) but the usefulness of the PPI for advanced cancer 
patients in the home care setting has not been established. The aims of this study were 
thus to clarify the sensitivity and specificity of the PPI for this particular population. 
 
Methods 
Our study population included all advanced cancer patients who received home 
visiting services regularly from Yamato Clinic between April 2007 and June 2009, and 
who died at home or in the hospital. Yamato Clinic provides ambulatory care and home 
visiting services for community residents, with 3 doctors specialized in family medicine 
and palliative care. We assessed the components of the PPI during the first home visit, 
as is our usual practice. In June 2010, one researcher (JH) then used medical records 
from patients’ first home visits to determine actual survival time as well as each 
component of the PPI: PPS score, oral intake, and the presence or absence of dyspnea, 
edema, and delirium. The PPI score was calculated for each patient, along with overall 
sensitivity and specificity. Survival predictions were defined as mentioned above: less 
than three weeks for PPI≥6, and less than 6 weeks for PPI≥4. 
This study was conducted in conformity with the Declaration of Helsinki and was 
carried out with special regard for the protection of individual data. 
 
Results 
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Sixty-five patients (41 males) were included in this study. Table 2 shows patient 
background information in detail. The mean patient age was 73.5, with 25 patients 
(38.4%) in their 70s and 14 patients (21.5%) in their 80s. The primary cancer site was 
the stomach/esophagus in 12 patients (18.4%), the lung in 11 patients (16.9%), and the 
colon/rectum/anus in 11 patients (16.9%). The mean survival time after the first home 
visit was 55 days. Survival time was shorter than 3 weeks in 22 patients (33.8%) and 
shorter than 6 weeks in 35 patients (53.8%) (Table 2). 
Twenty-one patients (32.3%) had PPI scores ≥6, while 29 (44.6%) had PPI scores ≥4 
(Table 3). The distribution of performance status and clinical symptoms is indicated in 
Table 4. Twelve patients with PPI scores ≥6 survived for less than 3 weeks, while 22 
patients with PPI scores ≥4 survived for less than 6 weeks (Tables 5, 6). Three-week 
survival was predicted with a sensitivity of 55% (95% CI, 33−75), a specificity of 79% 
(95% CI, 66−91), a positive predictive value of 57%, and a negative predictive value of 
77%. Six-week survival was predicted with a sensitivity of 63% (95% CI, 46−78), a 
specificity of 77% (95% CI, 61−91), a positive predictive value of 77%, and a negative 
predictive value of 64% (Table 7). 
 
Discussion 
The most important finding of this study was that the sensitivity of the PPI for advanced 
cancer patients in the home care setting was lower than for advanced cancer patients in 
palliative care units as previously reported.7) To the best of our knowledge, this study is 
the first to clarify the usefulness of the PPI for advanced cancer patients in the home 
care setting. It demonstrated the sensitivity and specificity of the PPI as a prognostic 
prediction tool for 3- and 6-week survival. Our findings suggest limitations of the PPI in 
Page 3 of 14
http://mc.manuscriptcentral.com/ajhpm
American Journal of Hospice and Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
4 
 
this population and setting. 
 One possible reason for the discrepancy in PPI sensitivity between advanced cancer 
patients in palliative care units and those in the home care setting is the differential 
prevalence of delirium, which is the most heavily weighted score in the PPI scoring 
system. In our study, the prevalence of delirium in the home care setting was 9.2%, 
whereas Morita et al.7) reported a prevalence of 23% in the hospice setting. This 
discrepancy suggests 2 possibilities: 1) The prevalence of delirium in the hospice setting 
may in fact be higher than that in the home care setting,9,10) or 2) we might have 
underestimated the prevalence of delirium because we diagnosed it only by 
retrospective chart review.   
In addition to the results above, we found the specificity of PPI for advanced cancer 
patients in the home care setting to be nearly 80% in our study for both 3- and 6-week 
survival. These results suggest that the PPI might not be useful as a screening tool for 
poor prognosis in the home care setting because of its low sensitivity, but might be 
useful with PPI scores <4, predicting survival longer than 6 weeks, and with PPI scores 
<6, predicting survival longer than 3 weeks. 
This study has several limitations. First, it was carried out in one institution and the 
study population was small, restricting the generalizability of our results. Second, one 
researcher (JH) was aware of each patient’s prognosis before performing the medical 
chart review, making it impossible to confirm the absence of bias during data collection. 
However, because the PPI score is defined based on objective indicators, this limitation 
most likely had only a relatively small effect on the study outcome. Third, since this 
study was carried out retrospectively, we cannot be certain that patients' symptoms and 
signs were recorded correctly at the first home visit.  
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In conclusion, this study showed that the PPI had a lower sensitivity for advanced 
cancer patients in the home care setting than for those in palliative care units. Further 
research is needed to develop more accurate prognostic prediction tools for use in the 
home care setting. 
Declaration of Conflicting Interests: The author(s) declared no conflicts of interest 
with respect to the authorship and/or publication of this article.  
Funding: The author(s) received no financial support for the research and/or authorship 
of this article. 
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Table 1. Palliative Prognostic Index  
    score 
Palliative Performance Scale 10%−20% 4 
 30%−50% 2.5 
 60% 0 
   
Oral intake Severely reduced 2.5 
 Moderately reduced 1 
 Normal 0 
   
Edema Present 1 
 Absent 0 
   
Dyspnea at rest Present 3.5 
 Absent 0 
   
Delirium Present 4 
  Absent 0 
Overall PPI score was calculated by adding each component 
score 
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Table 2. Patient background information (n = 65)   
    n (%) 
Gender Male 41 (63.0) 
 Female 24 (37.0) 
    
Mean age (years)✝  73.5 (35−96) 
    
    
Mean survival duration (days)✝  55.0 (1−344) 
    
Age distribution  35−49 2 (3.1) 
 50−59 7 (10.8) 
 60−69 11 (16.9) 
 70−79 25 (38.4) 
 80−89 14 (21.5) 
 90- 6 (9.2) 
    
Primary cancer site Stomach/Esophagus 12 (18.4) 
 Lung 11 (16.9) 
 Colon/rectum/anus 11 (16.9) 
 Pancreas 7 (10.8) 
 Prostate 4 (6.2) 
 Kidney/bladder 4 (6.2) 
 Liver 3 (4.6) 
 Breast 3 (4.6) 
 Biliary system 3 (4.6) 
 Unknown 3 (4.6) 
 Others 4 (6.2) 
    
Survival duration 0≤ week<1 11 (16.9) 
 1≤ week<2 8 (12.3) 
 2≤ week<3 3 (4.6) 
 3≤ week<4 7 (10.8) 
 4≤ week<5 2 (3.0) 
 5≤ week<6 4 (6.2) 
 6≤ week<7 7 10.8 
 7≤ week<8 0 (0.0) 
 8≤ week<9 3 (4.6) 
  9≤ week 20 (30.7) 
✝Mean (range)    
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Table 3. Distribution of PPI scores (n = 65) 
score n (%) 
0 3 (4.6) 
1≤ PPI ≤2 4 (6.2) 
PPI = 2.5 6 (9.2) 
3.5≤PPI<4 23 (35.4) 
4≤PPI<6 8 (12.3) 
6≤PPI≤8 13 (20.0) 
8.5≤PPI≤10 3 (4.6) 
10.5≤PPI≤12 5 (7.7) 
PPI≥12.5 0 (0.0) 
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Table 4. Patient performance status and symptoms (n = 65) 
    n (%) 
Palliative Performance Scale 10%−20% 6 (9.2) 
 30%−50% 51 (78.5) 
 60% 8 (12.3) 
    
Oral intake Severely reduced 11 (16.9) 
 Moderately reduced 36 (60) 
 Normal 15 (23.1) 
    
Edema Present 22 (33.8) 
 Absent 43 (66.2) 
    
Dyspnea at rest Present 14 (21.5) 
 Absent 51 (78.5) 
    
Delirium Present 6 (9.2) 
  Absent 59 (90.8) 
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Table 5. PPI score and 3-week survival     
  <3-week survival ≥3-week survival Total   
PPI≥6 12 9 21   
PPI<6 10 34 44   
Total 22 43 65   
      
 Number of patients surviving <3 weeks with PPI scores >6  
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Table 6. PPI score and 6-week survival     
  <6-week survival ≥6-week survival Total   
PPI≥4 22 7 29   
PPI<4 13 23 36   
Total 35 30 65   
      
 Number of patients surviving <6 weeks with PPI scores >4 
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Table 7. Accuracy of the PPI for advanced cancer patients in the home care setting 
  <3 weeks (%) <6 weeks (%) 
Sensitivity 54.5 62.8 
Specificity 79.0 76.6 
Positive Predictive Value 57.1 75.8 
Negative Predictive Value 77.2 63.8 
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